A new finding can help put off the disabling vision loss among patients with diabetes.
According to a study conducted by the Michigan State University, a particular type of lipid, or fat, thought to only exist in the skin, now lives in your eye and might play a major role in deterring the eye disease.
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Our study presents an unexpected finding that the connections between cells in the retinal blood vessels contain unusual, long-chain lipids that may keep vessels from leaking, possibly preventing diabetic retinopathy from occurring," said lead author Julia Busik.
Blood vessels in the retina are closely connected by structures called tight junctions, which are part of the blood-retinal barrier, a virtually impenetrable wall.
Busik, along with graduate student Nermin Kady, showed that these connecting structures contain omega-linked acyl-very long-chain ceramides - elongated lipids that appear to strengthen this barrier.
Diabetes can expose blood vessels to high levels of glucose and unhealthy amounts of lipids, which throws off the balance of nutrients that are transported throughout the body.
"When this becomes unbalanced, the vessels leak and become fragile, leading to the development of diabetic retinopathy," Busik said. "It appears though that these long-chain lipids and the enzymes that produce them can protect the retina and its blood vessels."
In cases of diabetes, the enzyme ELOVL4 is suppressed by the disease, which decreases its ability to produce these helpful lipids and prevent further damage.
"Incorporating more of the long-chain lipids into the eye could potentially be a new treatment down the road and involve injections or even eye drops," she said.
Lipids often get a bad rap due to their association with health issues such as high cholesterol and heart disease, but Busik is encouraged by what she's found.
"There are bad lipids and then there are good lipids," she said. "We've found good lipids in the eye that have the potential of changing the development of diabetic retinopathy."
The study appears in the journal Diabetes.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
